Hydrafacial Investor Day Presentation Deck

Uniquely positioned amidst medtech peers 2021 EBITDA Margin 99 70% 60% 50% 40% 30% 20% 10% 0% 0% 20% $5.3bn mkt cap $2.6bn mkt cap 40% $2.9bn mkt cap 60% Few medtech companies with better margin and growth profile 80% 100% 2018-2022E Revenue CAGR Source: FactSet as of 09/04/22; includes all publicly traded MedTech companies with a market cap $1bn+ traded on US-based exchanges. 120% 140% 160% 180% BEAUTYHEALTH™

View entire presentation